BioDelivery Sciences International

News & Media

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released via email or RSS.

Archives: Search / 2013 / 2012 / 2011

May 9, 2013
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 Financials
NDA filing for BUNAVAIL on track for mid-summer 2013
May 7, 2013
BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Apr 29, 2013
BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors
Mar 26, 2013
BioDelivery Sciences Expands Product Pipeline with Acquisition of Patented Topical Clonidine Gel for the Treatment of Painful Diabetic Neuropathy
Completed Phase 2 study demonstrated efficacy in a pain condition with significant unmet need
Mar 18, 2013
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2012 Annual Report
NDA filing for BEMA Buprenorphine/Naloxone (BUNAVAIL) on track for mid-2013